FinancialBuzz.com’s latest
The Buzz
Show: Featuring Our Corporate News Recap on “Auris Medical Provides Update on Bentrio Program in Allergy”
Auris Medical Holding Ltd. (NASDAQ: EARS)
, a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, and its affiliate Altamira Medica Ltd. today announced additional details on the outcomes from the clinical investigation of its Bentrio
TM
nasal spray in allergic rhinitis and provided an update on the regulatory pathway in the US for the intended use in allergy.
Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. The Company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125, in Phase 2) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201, post Phase 1b). Through its affiliate Altamira Medica, the Company is developing a nasal spray for protection against airborne viruses and allergens Bentrio
TM
(AM-301). In addition, Auris Medical has two Phase 3 programs under development: Sonsuvi® (AM-111) for acute inner ear hearing loss and Keyzilen® (AM-101) for acute inner ear tinnitus. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland.
For more information, please visit:
Auris Medical Holding Ltd.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.
The post
“The Buzz” Show: Auris Medical (NASDAQ: EARS) Provides Update on Bentrio Program in Allergy
first appeared on
Financial Buzz
.
For further details see:
“The Buzz” Show: Auris Medical (NASDAQ: EARS) Provides Update on Bentrio Program in Allergy